Two recent articles by Aspire2025 researchers have explored how tobacco sales in New Zealand could be more effectively regulated. The first examines licensing models that have been implemented overseas, while the second explores how provisions from the Psychoactive Substances Act 2013 could inform tobacco supply policies (both published in the NZ Medical Journal, 1 April 2016).
This blog overviews the findings in both articles and explains how stronger tobacco supply policies would contribute to the Government’s smokefree 2025 goal.
For further information, please contact:
Lindsay Robertson
University of Otago
email l.robertson@otago.ac.nz